SMTL ID : 6br3.2 (2 other biounits)

Structure of RORgt in complex with a novel inverse agonist TAK-828.

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.00 Å
Oligo State
homo-dimer
Ligands
2 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
2 x E3V: {cis-3-[(5R)-5-[(7-fluoro-1,1-dimethyl-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carbonyl]cyclobutyl}acetic acid(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Kono, M. et al., Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor gamma t Inverse Agonist. J. Med. Chem. (2018)
Release Date
2018-03-21
Peptides
Nuclear receptor ROR-gamma: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Nuclear receptor ROR-gamma

Related Entries With Identical Sequence

6br3.1 | 6br3.3